Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201
- PMID: 30218911
- DOI: 10.1016/j.ejmech.2018.09.006
Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201
Abstract
GluN2A containing N-methyl-D-aspartate receptors (NMDARs) are important ion channels in the central nervous system and highly involved in several different neurophysiological but also neuropathophysiological processes. However, current understanding of the contribution of GluN2A containing NMDARs in these processes is incomplete. Therefore, highly selective compounds are required to further investigate these ion channels. In 2010, TCN-201 (2), one of the first selective negative allosteric modulators was reported. While the binding site of 2 and the influence of the substitution pattern of the benzenesulfonamide part has been reported recently, detailed structure-activity-relationships of the diacylhydrazine part and the linked phenyl moiety are still missing. In order to examine the critical interactions between these moieties and the binding site, several TCN-201 analogs with modified diacylhydrazine part were synthesized. The negative allosteric effect was recorded by two-electrode voltage clamp (TEVC) experiments using GluN1a/GluN2A expressing Xenopus laevis oocytes. Our data led to the conclusion, that the terminal phenyl moiety is involved in a cation-π-interaction with the guanidinium moiety of Arg755 of the GluN1a subunit, which plays a crucial role for high activity. Additionally, structure optimization by replacing the phenyl moiety with a thiophen-2-yl (10c), indol-2-yl (10g) or indol-3-yl (10h) moiety significantly increased the activity of 2 by the factor 2.5. At a test compound concentration of 200 nM, the negative allosteric effect of the most potent ligands 10c, 10h and 17 was significantly influenced by the glycine concentration. Although glycine dependency is higher than those of the lead compound 4, 10c and 17 showed significantly higher negative allosteric effects than 4 at glycine concentrations from 1 μM up to 10 μM. The potent GluN2A-NMDA receptor inhibitors 10c, 10h and 17 did not influence the ion current of GluN2B-NMDA receptors.
Keywords: Electrophysiology; GluN2A selective antagonists; NMDA receptor; Synthesis; TCN-201; Two-electrode voltage clamp.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Systematic variation of the benzenesulfonamide part of the GluN2A selective NMDA receptor antagonist TCN-201.Eur J Med Chem. 2017 Mar 31;129:124-134. doi: 10.1016/j.ejmech.2017.02.018. Epub 2017 Feb 14. Eur J Med Chem. 2017. PMID: 28222314
-
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.Neuropharmacology. 2012 Sep;63(3):441-9. doi: 10.1016/j.neuropharm.2012.04.027. Epub 2012 May 1. Neuropharmacology. 2012. PMID: 22579927 Free PMC article.
-
Synthesis of GluN2A-selective NMDA receptor antagonists with an electron-rich aromatic B-ring.Eur J Med Chem. 2021 Jan 1;209:112939. doi: 10.1016/j.ejmech.2020.112939. Epub 2020 Oct 15. Eur J Med Chem. 2021. PMID: 33162207
-
Development of GluN2A NMDA receptor positive allosteric modulators: Recent advances and perspectives.Bioorg Med Chem. 2025 Jul 1;124:118194. doi: 10.1016/j.bmc.2025.118194. Epub 2025 Apr 10. Bioorg Med Chem. 2025. PMID: 40239379 Review.
-
Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes.J Labelled Comp Radiopharm. 2019 Jun 30;62(8):552-560. doi: 10.1002/jlcr.3744. J Labelled Comp Radiopharm. 2019. PMID: 31037756 Review.
Cited by
-
Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands.Acta Pharm Sin B. 2024 May;14(5):1987-2005. doi: 10.1016/j.apsb.2024.01.004. Epub 2024 Jan 10. Acta Pharm Sin B. 2024. PMID: 38799621 Free PMC article. Review.
-
[2.2]Paracyclophane-Based TCN-201 Analogs as GluN2A-Selective NMDA Receptor Antagonists.ChemMedChem. 2021 Oct 15;16(20):3201-3209. doi: 10.1002/cmdc.202100400. Epub 2021 Aug 3. ChemMedChem. 2021. PMID: 34265163 Free PMC article.
-
Evaluating the ability of in silico identified hit compounds to bind Staphylococcus aureus LcpASA using steered molecular dynamics simulations.Mol Divers. 2025 Mar 27. doi: 10.1007/s11030-025-11155-0. Online ahead of print. Mol Divers. 2025. PMID: 40146432
-
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity.Int J Mol Sci. 2020 Feb 24;21(4):1538. doi: 10.3390/ijms21041538. Int J Mol Sci. 2020. PMID: 32102377 Free PMC article. Review.
-
GluN2A-Selective NMDA Receptor Antagonists: Mimicking the U-Shaped Bioactive Conformation of TCN-201 by a [2.2]Paracyclophane System.ChemMedChem. 2022 Nov 4;17(21):e202200484. doi: 10.1002/cmdc.202200484. Epub 2022 Oct 13. ChemMedChem. 2022. PMID: 36169098 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous